Voorhees Seth Van's Net Worth
-$307 Thousand
Who is Voorhees Seth Van?
Voorhees Seth Van does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AMERICAN PACIFIC CORP, PDS Biotechnology Corp, RESEARCH FRONTIERS INC, and NRX Pharmaceuticals, Inc..
SEC CIK
Voorhees Seth Van's CIK is 0001284934
Past Insider Trading and Trends
2006 was Voorhees Seth Van's most active year for acquiring shares with 16 total transactions. Voorhees Seth Van's most active month to acquire stocks was the month of January. 2020 was Voorhees Seth Van's most active year for disposing of shares, totalling 5 transactions. Voorhees Seth Van's most active month to dispose stocks was the month of January. 2021 saw Voorhees Seth Van paying a total of $149,999.50 for 220,447 shares, this is the most they've acquired in one year. In 2020 Voorhees Seth Van cashed out on 155,091 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMERICAN PACIFIC CORP No price found
VP, CFO & Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.89K |
$5.71 | $33,649.03 | 5.89K |
Mar 1
| |||
Form 4
|
∞
| 15K |
$5.58 | $83,627.87 | 15K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDS Biotechnology Corp (PDSB) Snapshot price: $5.31
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 17.65K |
$8.50 | $149,999.50 | 17.65K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RESEARCH FRONTIERS INC (REFR) Snapshot price: $1.07
CFO & VP-Business Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +65.91% | 91.55K |
$1.36 | $124,963.24 | 230.45K |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +2.97% | 4K |
$1.15 | $4,600.00 | 138.9K |
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +1.50% | 2K |
$5.45 | $10,900.00 | 134.9K |
Dec 31 - Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +73.27% | 56.2K |
—
|
—
| 132.9K |
Jan 1
| |||
Form 4
| +113.06% | 40.7K |
—
|
—
| 76.7K |
Jan 1
| |||
Form 4
| +100.00% | 24K |
$8.65 | $207,600.00 | 48K |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NRX Pharmaceuticals, Inc. (NRXP) Snapshot price: $0.3989
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +183.63% | 30K |
$1.10 | $33,000.00 | 46.34K |
Dec 16
| |||
Form 4/A
|
∞
| 16.34K |
$1.11 | $18,215.23 | 16.34K |
Nov 25
| |||
Form 4
| +174.62% | 16.34K |
$1.12 | $18,215.23 | 25.69K |
Nov 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||